The hypocretins: Setting the arousal threshold

Nature Reviews Neuroscience

Volumn 3, Issue 5, 2002, Pages 339-349

  Sutcliffe, J Gregor ^a   de Lecea, Luis ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; OREXINS; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; AROUSAL; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; AROUSAL; CARRIER PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 0036580756     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn808     Document Type: Review

References (123)

1. Gautvik, K. M. et al. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl Acad. Sci. USA 93, 8733-8738 (1996).
2. de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA 95, 322-327 (1998).
3. Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585 (1998).
4. Alvarez, C. E. & Sutcliffe, J. G. Hypocretin is an early member of the incretin gene family. Neurosci. Lett. (in the press).
5. Lee, J. H. et al. Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B. Eur. J. Biochem. 299, 831-839 (1999).
6. 1H-NMR study of the solution conformation of secretin. Resonance assignment and secondary structure. FEBS Lett. 215, 88-94 (1987).
7. Trivedi, P, Yu, H., MacNeil, D. J., Van der Ploeg, L. H. T. & Guan, X.-M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438, 71-75 (1998).
8. Marcus, J. N. et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6-25 (2001).
9. Satinoff, E. & Shan, S. Y. Loss of behavioral thermoregulation after lateral hypothalamic lesions in rats. J. Comp. Physiol. Psychol. 77, 302-312 (1971).
10. Gilbert, T. M. & Blatteis, C. M. Hypothalamic thermoregulatory pathways in the rat. J. Appl. Physiol. 43, 770-777 (1977).
11. Levitt, D. R. & Teitelbaum, P. Somnolence, akinesia, and sensory activation of motivated behavior in the lateral hypothalamic syndrome. Proc. Natl Acad. Sci. USA 72, 2819-2823 (1975).
12. Trojniar, W., Jurkowlaniec, E., Orzel-Gryglewska, J. & Tokarski, J. The effect of lateral hypothalamic lesions on spontaneous EEG pattern in rats. Acta Neurobiol. Exp. 47, 27-43 (1987).
13. Bernardis, L. L. & Bellinger, L. L. The lateral hypothalamic area revisited: neuroanatomy, body weight regulation, neuroendocrinology and metabolism. Neurosci. Biobehav. Rev. 17, 141-193 (1993).
14. Bernardis, L. L. & Bellinger, L. L. The lateral hypothalamic area revisited: ingestive behavior. Neurosci. Biobehav. Rev. 20, 189-287 (1996).
15. Qu, D. et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243-247 (1996).
16. Peyron, C. et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015 (1998).
17. Broberger, C., de Lecea, L., Sutcliffe, J. G. & Hökfelt, T. Hypocretin/orexin-and melanin-concentrating hormone- expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 402, 460-474 (1998).
18. Elias, C. F. et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 402, 442-459 (1998).
19. Hakansson, M., de Lecea, L., Sutcliffe, J. G., Yanagisawa, M. & Meister, B. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurons of the lateral hypothalamus. J. Neuroendocrinol. 11, 653-663 (1999).
20. Chou, T C. et al. Orexin (hypocretin) neurons contain dynorphin. J. Neurosci. 21, RC168 (2001).
21. Abrahamson, E. E., Leak, R. K. & Moore, R. Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12, 435-440 (2001).
22. Date, Y et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl Acad. Sci. USA 96, 748-753 (1999).
23. Van den Pol, A. N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 19, 3171-3182 (1999).
24. Moore, R. Y., Abrahamson, E. A. & Van Den Pol, A. The hypocretin neuron system: an arousal system in the human brain. Arch. Ital. Biol. 139, 195-205 (2001).
25. Horvath, T. L., Diano, S. & Van den Pol, A. N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 19, 1072-1087 (1999).
26. Van den Pol, A. N., Gao, X.-B., Obrietan, K., Kilduff, T. S. & Belousov, A. B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18, 7962-7971 (1998).
27. Shirasaka, T. et al. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1114-R1118 (2001).
28. Hagan, J. J. et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl Acad. Sci. USA 96, 10911-10916 (1999).
29. 2+ channels. Neuroreport 12, 2017-2020 (2001).
30. Smart, D. et al. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary 55. cell-line using FLIPR. Br. J. Pharmacol. 128, 1-3 (1999).
31. 2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 12, 1885-1889 (2001).
32. Randeva, H. S., Karteris, E., Grammatopoulos, D. & Hillhouse, E. W. Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals, implications 57. for adrenal function and energy homeostasis. J. Clin. Endocrinol. Metab. 86, 4808-4813 (2001).
33. Karteris, E., Randeva, H. S., Grammatopoulos, D. K., Jaffe, R. B. & Hillhouse, E. W. Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J. Clin. Endocrinol. Metab. 86, 4512-4519 (2001).
34. Martin, G., Fabre, V., Siggins, G. R. & de Lecea, L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul. Pept. 104, 111-117 (2002).
35. Mondal, M. S. et al. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem. Biophys. Res. Commun. 256, 495-499 (1999).
36. Dube, M. G., Kalra, S. P & Kalra, P S. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res. 842, 473-477 (1999).
37. Sartin, J. L. et al. Effect of intracerebroventricular orexin-B on food intake in sheep. J. Anim. Sci. 79, 1573-1577 (2001).
38. Yamamoto, Y et al. Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res. Mol. Brain Res. 65, 14-22 (1999).
39. Jain, M. R., Hoivath, T. L., Kalra, P S. & Kalra, S. P. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul. Pept. 87, 19-24 (2000).
40. Yamanaka, A. et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 859, 404-409 (2000).
41. Beck, B. & Richy, S. Hypothalamic hypocretin/orexin and neuropeptide Y, divergent interaction with energy depletion and leptin. Biochem. Biophys. Res. Commun. 258, 119-122 (1999).
42. Lopez, M. et al. Leptin regulation of prepro-orexin and orexin 67. receptor mRNA levels in the hypothalamus. Biochem. Biophys. Res. Commun. 269, 41-45 (2000).
43. Niimi, M., Sato, M. & Taminato, T. Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine 14, 269-273 (2001).
44. Yamada, H., Okumura, T., Motomura, W., Kobayashi, Y. & Kohgo, Y. Inhibition of food intake by central injection of anti- orexin antibody in fasted rats. Biochem. Biophys. Res. Commun. 267, 527-531 (2000).
45. Lawrence, C. B., Snape, A. C., Baudoin, F. M. & Luckman, S. M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 71. 143, 155-162 (2002).
46. Griffond, B., Risold, P Y., Jacquemard, C., Colard, C. & Fellmann, D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci. Lett. 262, 77-80 (1999).
47. Moriguchi, T., Sakurai, T., Nambu, T., Yanagisawa, M. & Goto, K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett. 264, 101-104 (1999).
48. Bayer, L. et al. Alteration of the expression of the hypocretin (orexin) gene by 2-deoxyglucose in the rat lateral hypothalamic area. Neuroreport 11, 531-533 (2000).
49. Cai, X. J. et al. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50, 105-112 (2001).
50. 2+ in orexin neurons of the rat lateral hypothalamus. Neurosci. Lett. 309, 165-168 (2001).
51. Ida, T., Nakahara, K., Katayama, T., Murakami, N. & Nakazato, M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 821, 526-529 (1999).
52. Lubkin, M. & Stricker-Krongrad, A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 253, 241-245 (1998).
53. Edwards, C. M. et al. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin- concentrating hormone and galanin. J. Endocrinol. 160, R7-R12 (1999).
54. Sweet, D. C., Levine, A. S., Billington, C. J. & Kotz, C. M. Feeding response to central orexins. Brain Res. 821, 535-538 (1999).
55. Taheri, S., Mahmoodi, M., Opacka-Juffry, J., Ghatei, M. A. & Bloom, S. R. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett. 457, 157-161 (1999).
56. Tritos, N. A., Mastaitis, J. W., Kokkotou, E. & Maratos-Flier, E. Characterization of melanin-concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Res. 895, 160-166 (2001).
57. Swart, I., Overton, J. M. & Houpt, T. A. The effect of food deprivation and experimental diabetes on orexin and NPY mRNA levels. Peptides 22, 2175-2179 (2001).
58. Yoshida, Y et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14, 1075-1081 (2001).
59. Fujiki, N. et al. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12, 993-997 (2001).
60. Yamanaka, A., Sakurai, T, Katsumoto, T, Yanagisawa, M. & Goto, K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res. 849, 248-252 (1999).
61. Dampney, R. A. L. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 74, 323-364 (1994).
62. Iqbal, J., Pompolo, S., Sakurai, T. & Clarke, I. J. Evidence that orexin-containing neurones provide direct input to gonadotropin-releasing hormone neurones in the ovine hypothalamus. J. Neuroendocrinol. 13, 1033-1041 (2001).
63. Sherin, J. E., Shiromani, P. J., McCarley, R. W. & Saper, C. B. Activation of ventrolateral preoptic neurons during sleep. Science 271, 216-219 (1996).
64. Kirchgessner, A. L. & Liu, M.-T. Orexin synthesis and response in the gut. Neuron 24, 941-951 (1999).
65. Samson, W. K., Gosnell, B., Chang, J. K., Resch, Z. T. & Murphy, T. C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 831, 248-253 (1999).
66. Shirasaka, T., Nakazato, M., Matsukura, S., Takasaki, M. & Kannan, H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277, R1780-R1785 (1999).
67. Chen, C. T., Hwang, L. L., Chang, J. K. & Dun, N. J. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R692-R697 (2000).
68. Wang, J., Osaka, T. & Inoue, S. Energy expenditure by intracerebroventricular administration of orexin to anesthetized rats. Neurosci. Lett. 315, 49-52 (2001).
69. Yoshimichi, G., Yoshimatsu, H., Masaki, T. & Sakata, T. Orexin-A regulates body temperature in coordination with arousal status. Exp. Biol. Med. 226, 468-476 (2001).
70. Kunii, K. et al. Orexins/hypocretins regulate drinking behaviour. Brain Res. 842, 256-261 (1999).
71. Takahashi, N., Okumura, T., Yamada, H. & Kohgo, Y. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem. Biophys. Res. Commun. 254, 623-627 (1999).
72. Piper, D. C., Upton, N., Smith, M. I. & Hunter, A. J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12, 726-730 (2000).
73. Bourgin, P. et al. Hypocretin-1 modulates REM sleep through activation of locus coeruleus neurons. J. Neurosci. 20, 7760-7765 (2000).
74. Espana, R. A., Baldo, B. A., Kelley, A. E. & Berridge, C. W. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106, 699-715 (2001).
75. Thakkar, M. M., Ramesh, V., Strecker, R. E. & McCarley, R. W. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139, 313-328 (2001).
76. Pu, S., Jain, M. R., Kalra, P. S. & Kalra, S. P. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner Requl. Pept. 78, 133-136 (1998).
77. Russell, S. H. et al. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 142, 5294-5302 (2001).
78. Malendowicz, L. K., Tortorella, C. & Nussdorfer, G. G. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J. Steroid Biochem. Mol. Biol. 70, 185-188 (1999).
79. Nowak, K. W., Mackowiak, P., Switonska, M. M., Fabis, M. & Malendowicz, L. K. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci. 66, 449-454 (2000).
80. Ida, T. et al. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 270, 318-323 (2000).
81. Russell, S. H. et al. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J. Neuroendocrinol. 13, 561-566 (2001).
82. Jones, D. N. et al. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B- induced hyperactivity. Psychopharmacoloqy 153, 210-218 (2001).
83. Samson, W. K. & Taylor, M. M. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am. J. Physiol. Requl. Inteqr. Comp. Physiol. 281, R1140-R1145 (2001).
84. Mikkelsen, J. D. et al. Hypocretin (orexin) in the rat pineal gland: a central transmitter with effects on noradrenaline- induced release of melatonin. Eur. J. Neurosci. 14, 419-425 (2001).
85. Grudt, T. J., Van Den Pol, A. N. & Perl, E. R. Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat. J. Physiol. (Lond.) 538, 517-525 (2002).
86. Bingham, S. et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 92, 81-90 (2001).
87. Lin, L. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365-376 (1999).
88. Hungs, M. et al. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res. 11, 531-539 (2001).
89. Jones, B. in Principles and Practice of Sleep Medicine (eds Kryger, M., Roth, T. & Dement, W. C.) 145-162 (W. B. Saunders, Philadelphia, 1994).
90. Steriade, M., McCormick, D. A. & Sejnowski, T. J. Thalamocortical oscillations in the sleeping and aroused brain. Science 262, 679-685 (1993).
91. McCormick, D. A. & Bal, T. Sleep and arousal: thalamocortical mechanisms. Annu. Rev. Neurosci. 20, 185-215 (1997).
92. Saper, C. B., Chou, T. C. & Scammell, T. E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 24, 726-731 (2001).
93. Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451 (1999).
94. Gerashchenko, D. et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J. Neurosci. 21, 7273-7283 (2001).
95. Willie, J. T., Chemelli, R. M., Sinton, C. M. & Yanagisawa, M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24, 429-458 (2001).
96. Mignot, E. et al. Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 68, 686-699 (2001).
97. Nishino, S., Ripley, B., Overeem, S., Lammers, J. G. & Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39-40 (2000).
98. Ripley, B. et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neuroloqy 57, 2253-2258 (2001).
99. Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Med. 6, 991-997 (2000).
100. Lin, L., Hungs, M. & Mignot, E. Narcolepsy and the HLA region. J. Neuroimmunol. 117, 9-20 (2001).
101. Alam, M. N. et al. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J. Physiol. (Lond.) 538, 619-631 (2002).
102. Estabrooke, I. V. et al. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21, 1656-1662 (2001).
103. Terao, A. et al. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice. Sleep 23, 867-874 (2000).
104. Greco, M. A. & Shiromani, P. J. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res. Mol. Brain Res. 88, 176-182 (2001).
105. Hobson, J. A., McCarley, R. W. & Wyzinski, P. W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189, 55-58 (1975).
106. Aston-Jones, G. & Bloom, F. E. Activity of norepinephrine- containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1, 876-886 (1981).
107. Horvath, T. L. et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415, 145-159 (1999).
108. Ivanov, A. & Aston-Jones, G. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport 11, 1755-1758 (2000).
109. Brown, R. E., Sergeeva, O., Eriksson, K. S. & Haas, H. L. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacoloqy 40, 457-459 (2001).
110. Bayer, L. et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci. 14, 1571-1575 (2001).
111. Yamanaka, A. et al. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun. 290, 1237-1245 (2002).
112. Huang, Z. L. et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl Acad. Sci. USA 98, 9965-9970 (2001).
113. Hungs, M. & Mignot, E. Hypocretin/orexin, sleep and narcolepsy. Bioessays 23, 397-408 (2001).
114. de Lecea, L. et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381, 242-245 (1996).
115. Xi, M. C., Morales, F. R. & Chase, M. H. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res. 901, 259-264 (2001).
116. Kilduff, T. S. & Peyron, C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 23, 359-365 (2000).
117. Eggermann, E. et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108, 177-181 (2001).
118. John, J., Wu, M. F. & Siegel, J. M. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res. Online 3, 23-28 (2000).
119. Kastin, A. J., Pan, W., Maness, L. M. & Banks, W. A. Peptides crossing the blood-brain barrier: some unusual observations. Brain Res. 848, 96-100 (1999).
120. Fujiki, N., Yoshida, Y., Ripley, B., Mignot, E. & Nishino, S. Effect of systemic and central administration of hypocretin 1 in narcoleptic (Hcrtr2 mutated) and control dogs. Sleep 24, A96 (2001).
121. Nishino, S. et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 50, 381-388 (2001).
122. Schuld, A., Hebebrand, J., Geller, F. & Pollmacher, T. Increased body-mass index in patients with narcolepsy. Lancet 355, 1274-1275 (2000).
123. Hara, J. et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345-354 (2001).